Breaking News Instant updates and real-time market news.

GWPH

GW Pharmaceuticals

$132.50

-0.86 (-0.64%)

14:39
04/19/18
04/19
14:39
04/19/18
14:39

GW Pharmaceuticals CEO says should take 90 days for DEA scheduling

GW Pharmaceuticals CEO Justin Gover said it should take 90 days for DEA scheduling of cannabidiol oral solution, also known as Epidiolex. Gover said he will not comment right now on pricing or sales forecasts for Epidiolex, which just received a positive panel backing from an FDA Advisory Committee. Gover is being interviewed on CNBC.

  • 19

    Apr

  • 21

    May

  • 27

    Jun

GWPH GW Pharmaceuticals
$132.50

-0.86 (-0.64%)

01/23/18
LEER
01/23/18
NO CHANGE
Target $153
LEER
Outperform
Leerink cautiously optimistic ahead of GW Pharmaceuticals CBDV Phase 2 data
Leerink analyst Paul Matteis reiterates an Outperform rating on GW Pharmaceuticals, while lowering his price target on the shares to $153 from $154, ahead of CBDV Phase II data in partial-onset seizures in Q1. While he acknowledges that is difficult to garner conviction in the Phase 2, his analysis of pre-clinical results - compared side-by-side to cannabidiol - instills him with "cautious optimism" on the program, while he believes that the little credit priced into the stock for CBDV sets up an upside skewed risk/reward on the upcoming data readout this quarter.
02/06/18
CANT
02/06/18
NO CHANGE
Target $192
CANT
Overweight
GW Pharmaceuticals price target lowered to $192 from $208 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros lowered his price target for GW Pharmaceuticals to $192 following the company's Q1 financial results and recent equity raise. The analyst, however, believes the shares remain "significantly undervalued," based on his assessment of Epidiolex's opportunity in treating orphan pediatric epileptic conditions. He reiterates an Overweight rating on GW.
02/22/18
CANT
02/22/18
NO CHANGE
Target $192
CANT
Overweight
GW Pharmaceuticals shares could recover quickly, says Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros believes GW Pharmaceuticals shares could recover quickly from the selloff on the negative results with GWP42006 in adult patients with focal seizures. The analyst highlights the announcement of an advisory committee hearing for Epidiolex on April 18. The "clear near-term focus" is the successful commercialization of Epidiolex for pediatric pharmacoresistant seizures upon potential approval in the second half of 2018, Piros tells investors in a research note. He keeps an Overweight rating on GW shares with a $192 price target.
04/19/18
CANT
04/19/18
NO CHANGE
Target $205
CANT
Overweight
GW Pharmaceuticals price target raised to $205 from $192 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros raised his price target for GW Pharmaceuticals to $205 and reiterates an Overweight rating on the shares after an FDA advisory committee voted 13-0 that the benefit-risk profile of cannabidiol is favorable for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients two years of age and older.

TODAY'S FREE FLY STORIES

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

18:30
09/25/18
09/25
18:30
09/25/18
18:30
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

INGN

Inogen

$258.49

5.5 (2.17%)

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 09

    Oct

  • 19

    Oct

  • 27

    Nov

TJX

TJX

$110.33

0.605 (0.55%)

18:27
09/25/18
09/25
18:27
09/25/18
18:27
Initiation
TJX initiated  »

TJX initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYH

Community Health

$3.41

-0.08 (-2.29%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Hot Stocks
Breaking Hot Stocks news story on Community Health »

Community Health up 3.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AFL

Aflac

$47.69

-0.01 (-0.02%)

18:25
09/25/18
09/25
18:25
09/25/18
18:25
Conference/Events
Aflac to hold financial analysts briefing »

Financial Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

TPC

Tutor Perini

$19.55

-0.275 (-1.39%)

18:12
09/25/18
09/25
18:12
09/25/18
18:12
Hot Stocks
Tutor Perini awarded $82M aircraft maintenance contract »

Tutor Perin announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLTH

Nobilis Health

$0.95

-0.0494 (-4.94%)

18:01
09/25/18
09/25
18:01
09/25/18
18:01
Hot Stocks
Nobilis Health names Kenny Klein new CFO »

Nobilis Health announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:57
09/25/18
09/25
17:57
09/25/18
17:57
Syndicate
FlexShopper 10M share Secondary priced at $1.00 »

Credit Suisse acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPAY

FlexShopper

$1.16

-0.69 (-37.30%)

17:55
09/25/18
09/25
17:55
09/25/18
17:55
Syndicate
FlexShopper 10M unit Secondary priced at $1.00 »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:48
09/25/18
09/25
17:48
09/25/18
17:48
Hot Stocks
Nike says Jordan brand 'incredibly strong' in China »

Says relationship with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:45
09/25/18
09/25
17:45
09/25/18
17:45
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says recent ad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CYH

Community Health

$3.41

-0.08 (-2.29%)

17:43
09/25/18
09/25
17:43
09/25/18
17:43
Hot Stocks
Community Health reaches settlement pact with DOJ over HMA probe »

Community Health Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike sees FY19 gross…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:39
09/25/18
09/25
17:39
09/25/18
17:39
Earnings
Nike sees 'strong' sequential revenue growth in Q2 »

Sees Q2 gross margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:38
09/25/18
09/25
17:38
09/25/18
17:38
Hot Stocks
KB Home CEO sees slower sales in higher priced homes »

Comments from Q3 earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MTBC

Medical Transcription Billing

$4.96

0.2 (4.20%)

17:36
09/25/18
09/25
17:36
09/25/18
17:36
Syndicate
Breaking Syndicate news story on Medical Transcription Billing »

Medical Transcription…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.79

0.52 (0.62%)

17:34
09/25/18
09/25
17:34
09/25/18
17:34
Hot Stocks
Breaking Hot Stocks news story on Nike »

Nike says has seen 17…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

GTX

Garrett Motion

$0.00

(0.00%)

, ACET

Aceto

$2.83

-0.09 (-3.08%)

17:30
09/25/18
09/25
17:30
09/25/18
17:30
Hot Stocks
Garrett Motion to replace Aceto in S&P 600 at open on October 2 »

Honeywell (HON) is…

GTX

Garrett Motion

$0.00

(0.00%)

ACET

Aceto

$2.83

-0.09 (-3.08%)

HON

Honeywell

$165.59

0.12 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

NKE

Nike

$84.79

0.52 (0.62%)

17:27
09/25/18
09/25
17:27
09/25/18
17:27
Hot Stocks
Nike says has returned to 'strong, sustainable growth' in North America »

Says facets of live story…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RBNC

Reliant Bancorp

$25.91

-0.27 (-1.03%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Reliant Bancorp raises quarterly cash dividend 33% from last year »

Reliant Bancorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

, INGN

Inogen

$258.49

5.5 (2.17%)

17:25
09/25/18
09/25
17:25
09/25/18
17:25
Hot Stocks
Breaking Hot Stocks news story on Vanda Pharmaceuticals, Inogen »

Vanda Pharmaceuticals to…

VNDA

Vanda Pharmaceuticals

$20.70

0.3 (1.47%)

INGN

Inogen

$258.49

5.5 (2.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 09

    Oct

  • 27

    Nov

INGN

Inogen

$258.49

5.5 (2.17%)

, ROL

Rollins

$62.46

0.74 (1.20%)

17:23
09/25/18
09/25
17:23
09/25/18
17:23
Hot Stocks
Breaking Hot Stocks news story on Inogen, Rollins »

Inogen to replace Rollins…

INGN

Inogen

$258.49

5.5 (2.17%)

ROL

Rollins

$62.46

0.74 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 09

    Oct

  • 27

    Nov

KBH

KB Home

$25.29

-0.24 (-0.94%)

17:20
09/25/18
09/25
17:20
09/25/18
17:20
Hot Stocks
KB Home sees FY18 housing revenue of $4.6B, low end of prior $4.6B-$4.8B view »

Sees FY18 gross margin of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ROL

Rollins

$62.46

0.74 (1.20%)

, ANDV

Andeavor

$157.60

-1.41 (-0.89%)

17:18
09/25/18
09/25
17:18
09/25/18
17:18
Hot Stocks
Rollins to replace Andeavor in S&P 500 at open on October 1 »

S&P 500 constituent…

ROL

Rollins

$62.46

0.74 (1.20%)

ANDV

Andeavor

$157.60

-1.41 (-0.89%)

MPC

Marathon Petroleum

$85.04

-0.78 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:15
09/25/18
09/25
17:15
09/25/18
17:15
Hot Stocks
Nike says apparel saw 11% growth in Q1 »

Says apparel saw 11%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NKE

Nike

$84.79

0.52 (0.62%)

17:15
09/25/18
09/25
17:15
09/25/18
17:15
Hot Stocks
Nike says apparel saw 11% growth in Q1 »

Says apparel saw 11%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.